Notably, the law gives the federal government the power to negotiate prescription drug prices.

This means that individuals that do not have health insurance or are underinsured will have to pay either the full price of the drugs, or a still large amount of the money.

[6] Several polls have shown that a large share of the population has skipped filling drugs that were medically necessary because of the cost.

[7][8][9][10][11][12][13][14] Insurance companies generally have pharmacy benefit managers negotiate discounts for drug prices on their behalf.

[15][16] The bill would require the Department of Health and Human Services (HHS) to negotiate certain drug prices.

Any drug manufacturers that do not comply with the law's negotiation requirements may be fined or receive tax penalties.

Under Part D, when the costs of drugs rise, the person enrolled in Medicare must pay more in out-of-pocket expenses.

The HHS would be required to start a grant program so states can establish commissions to target unnecessary administrative costs as well.

The CMS had planned to establish a similar rule, but a federal court had struck it down on the basis that they did not have the power to do so.